Hyperbaric oxygen therapy is used internationally for more than 80 different conditions. Research supports its use for athletic injuries and performance, arthritis, autism, attention deficit disorder, auto-immune disorders, Bell’s Palsy, brain and head injuries, cardiovascular disease, cerebral palsy, Crohn’s disease, dermatological conditions, diabetes, dementia, interstitial cystitis, irritable bowel syndrome and colitis, Lyme disease, learning disabilities, macular degeneration, multiple sclerosis, neuropathies, pervasive development disorders, PTSD, reflex sympathetic dystrophy, reconstructive surgery, spinal cord injury, stroke, and more. Research is showing that it may be effective as an anti-aging and cancer prevention strategy.
HBOT is FDA approved to treat air or gas embolism, carbon monoxide & cyanide poisoning, crush injury, acute traumatic ischemia, decompression sickness, delayed radiation injury, diabetic foot ulcers, enhanced healing of problem wounds, exceptional blood loss, gas gangrene, intracranial abscess, necrotizing soft tissue infections, osteomyelitis (refractory), skin grafts and flaps(compromised), and thermal burns.
Portable hyperbaric chambers are cleared by the FDA to treat acute mountain sickness only. All other conditions treated by portable hyperbaric chambers are considered off-label uses. Many of these uses are quite commonplace in countries such as Russia, China, Japan, Italy, and the U.K.